Oramed Pharmaceuticals Inc Share Price

NASDAQ: ORMP

Small Cap

$2.32

(+0.16%)

Live

as on September 16, 2025 at 7:38 pm IST

$₹

Oramed Pharmaceuticals Inc Stock Performance

as on September 16, 2025 at 7:38 pm IST

Day's Low
$2.27
Day's Price Range
$2.32
$2.32
2.16%
Downside
52 Week's Low
52 Week's High
$1.82
52-Week Price Range
$3.09
$2.32
21.55%
Downside
33.19%
Upside

Oramed Pharmaceuticals Inc share price movements today

Previous Close: $2.32
Open: $2.31
Volume: 4.4K
Day's Low - High: $2.27 - $2.32
52 Week Low - High: $1.82 - $3.09

Oramed Pharmaceuticals Inc Historical Returns

1 Month Return: + 11.54 %
3 Month Return: + 7.41 %
1 Year Return: -6.45 %
3 Year Return: -69.79 %
5 Year Return: 0 %

Oramed Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Oramed Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$95.1M

EPS (TTM)

-0.34

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.41%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-13.5M

Revenue (TTM)

2.0M

Profit Margin

0.00%

Return On Equity TTM

30990300.00%

Oramed Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oramed Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Oramed Pharmaceuticals Inc	HOLD	$95.1M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Oramed Pharmaceuticals Inc Stock including INR - Dollar returns

The Oramed Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Oramed Pharmaceuticals Inc investment value today

Current value as on today

₹98,416

Returns

₹1,584

(-1.58%)

Returns from Oramed Pharmaceuticals Inc Stock

₹6,452 (-6.45%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Oramed Pharmaceuticals Inc Stock

Based on 7 analysts

HOLD

0.00%

Buy

57.14%

Hold

42.86%

Sell

Based on 7 analysts, 57.14% of analysts recommend a 'HOLD' rating for Oramed Pharmaceuticals Inc. Average target price of $3.25

Oramed Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Oramed Pharmaceuticals Inc.

What analysts predicted

28.62%UPSIDE

Target Price

$3.25

Current Price

$2.32

Analyzed by

7 Analysts

Target

$3.25

Oramed Pharmaceuticals Inc target price $3.25, a slight upside of 28.62% compared to current price of $2.32. According to 7 analysts rating.

Oramed Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Oramed Pharmaceuticals Inc Stock has increased by 325% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:325% versus previous 30 day period

Oramed Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Nov 2023	Dec 2023	Feb 2024	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	2	-
Gross Profit	-	-	-	-	-	-	-	0	0	0
Operating Income	-2	-	-3	-	-2	-3	-3	-3	-4	-2
EBITDA	-2	-	14	-	2	11	-3	-9	-4	13
Interest Expense	0	-	1	-	0	0	15	-15	2	-
Depreciation	0	-	0	-	0	0	0	0	0	0
Income Before Tax	-3	-	13	-	1	10	-18	-9	-7	13
Income Tax Expense	0	-	-	-	-	1	1	0	0	0
Net Income	-3	13	13	1	1	9	-19	-10	-7	13
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-382.10%	0.00%

Oramed Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Aug 2020	Dec 2020	Aug 2021	Dec 2021	Aug 2022	Dec 2022	Aug 2023	Dec 2023	Dec 2024
Total Revenue	2	2	2	2	2	2	2	2	1	-
Gross Profit	2	-	2	-	2	-	2	-	1	0
Operating Income	-14	-	-11	-	-24	-	-40	-	-15	-12
EBITDA	-14	-	-11	-	-25	-	-36	-	-15	-14
Interest Expense	0	-	-	-	0	-	2	-	3	0
Depreciation	-	-	0	-	0	-	0	-	0	0
Income Before Tax	-14	-	-11	-	-22	-	-37	-	5	-15
Income Tax Expense	0	-	0	-	-2	-	0	-	-	3
Net Income	-14	-11	-11	-22	-22	-36	-37	-37	5	-19
Net Profit Margin	-531.08%	-424.76%	-424.76%	-822.72%	-822.72%	-1352.61%	-1397.11%	-1397.11%	412.31%	0.00%

Oramed Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-1	-3	13	1	9	-19	-10	-7	13
Operating Cash Flow	-2	0	-1	-1	2	-7	-1	-3	-3
Investing Cash Flow	-14	-75	29	29	94	-34	15	23	-54
Financing Cash Flow	19	74	-25	-19	-30	-1	-1	-	0
Change in Cash	-17	-1	3	9	66	-42	12	20	-58

Oramed Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-10	-10	-12	-14	-11	-22	-37	5	-19
Operating Cash Flow	4	-5	-14	-12	-12	-21	-27	-10	-8
Investing Cash Flow	-16	4	-7	11	4	-23	30	-73	105
Financing Cash Flow	12	1	22	-	23	102	10	51	-52
Change in Cash	0	0	1	-1	15	57	13	-31	45

Global Institutional Holdings in Oramed Pharmaceuticals Inc

Funds	Holdings
BML Capital Management LLC	7.4%
Murchinson Ltd.	4.29%
BOOTHBAY FUND MANAGEMENT, LLC	2.07%
Rathbone Brothers PLC	0.57%
Two Sigma Advisers, LLC	0.52%

See all

Insights on Oramed Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, ORMP stock has moved up by 11.5%
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, -19.61M → 13.28M (in $), with an average increase of 94.5% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 666.0K → 2.0M (in $), with an average increase of 22.5% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 77.1%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 186.3%

About Oramed Pharmaceuticals Inc

oramed pharmaceuticals (nasdaqcm:ormp) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 trials under the usfda, the company is seeking to revolutionize the treatment of diabetes. read more: http://www.oramed.com/investors/corporate-presentation watch: https://www.youtube.com/watch?v=5qchxtdv9eg

Organisation	Oramed Pharmaceuticals Inc
Headquarters	1185 Avenue of the Americas, New York, NY, United States, 10036
Industry	Health Technology
CEO	Mr. Nadav Kidron Esq.
E-voting on shares	Click here to vote

Key Management of Oramed Pharmaceuticals Inc

Name	Title
Dr. Miriam Kidron Ph.D.	Chief Scientific Officer & Director
Mr. Nadav Kidron Esq.	President, CEO & Executive Chairman
Mr. Avraham Gabay	CFO, Treasurer & Secretary
Mr. Joshua Hexter	Chief Operating & Business Officer

FAQs

What is Oramed Pharmaceuticals Inc share price today?

Oramed Pharmaceuticals Inc share price today is $2.32 as on September 16, 2025 at 7:38 pm IST. Oramed Pharmaceuticals Inc share today touched a day high of $2.32 and a low of $2.27.

What is the 52 week high and 52 week low for Oramed Pharmaceuticals Inc share?

Oramed Pharmaceuticals Inc share touched a 52 week high of $3.09 on February 11, 2025 and a 52 week low of $1.82 on April 9, 2025. Oramed Pharmaceuticals Inc stock price today i.e. September 16, 2025 at 7:38 pm IST is trending at $2.32,which is 24.92% down from its 52 week high and 27.47% up from its 52 week low.

What is Oramed Pharmaceuticals Inc's market capitalisation today?

Oramed Pharmaceuticals Inc market capitalisation is $0.00T as on September 16, 2025 at 7:38 pm IST.

How to invest in Oramed Pharmaceuticals Inc Stock (ORMP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Oramed Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oramed Pharmaceuticals Inc Shares that will get you 0.6466 shares as per Oramed Pharmaceuticals Inc share price of $2.32 per share as on September 16, 2025 at 7:38 pm IST.

What is the minimum amount required to buy Oramed Pharmaceuticals Inc Stock (ORMP) from India?

Indian investors can start investing in Oramed Pharmaceuticals Inc (ORMP) shares with as little as ₹88.042 or $1 (as of September 16, 2025 at 8:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Oramed Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 8:41 pm IST). Based on Oramed Pharmaceuticals Inc share’s latest price of $2.32 as on September 16, 2025 at 7:38 pm IST, you will get 4.3103 shares of Oramed Pharmaceuticals Inc. Learn more about fractional shares .